Abuse was normalised in our home
"I had a pristine frontage of a middle-class home - no one thought it could happen behind those doors, but it did."
David Challen successfully campaigned to free his mother, Sally Challen, from prison in 2019, almost nine years after she had killed his father, Richard, with a hammer.
She had suffered decades of coercive control at the hands of her husband, which David said had become "normalised" within the family home in the wealthy suburban village of Claygate in Surrey.
David, now a domestic abuse campaigner, has now written a book, called The Unthinkable, about the family's experiences, and said more needs to be done to protect victims.
Speaking to Sunday with Laura Kuenssberg on BBC One, he said: "She'd done the worst act anyone possibly could do. [She] took away my father.
"I couldn't understand it, but I knew something had been rolling... something was happening and I just didn't have the words."
A law passed in 2015, which recognises psychological manipulation as a form of domestic abuse, helped secure Mrs Challen's release from prison after she had been jailed for life for murder in 2011.
Coercive control describes a pattern of behaviour by an abuser to harm, punish or frighten their victim and became a criminal offence in England and Wales in December 2015.
David said this description had set him and his mother "free".
"It gave us a language to describe what was going on in that home, to describe the insidious nature that is mostly non-physical violence," he said.
Not having a name for the abuse had "robbed us of our right to have an ability to protect ourselves," he added.
He now uses his experience of "intergenerational trauma" to help others, with a book telling the family's story being released on Thursday.
"I buried my childhood with my father, so I had to dig up the past to find the child I had left behind," he said.
"It was the child that I always hid because I didn't know how he experienced that world.
"But I knew I was born into this world with a gut feeling that [there was] something inherently bad about my father, and I never knew why.
"I normalised the coercion and control in my home, this life of servitude that my mother lived under... sexual violence was routine."
If you are affected by any of the issues raised in this article, help and support is available via the BBC Action Line.
He said he wrote the book to "give voice to what it's like to grow up in a home where domestic abuse wasn't the word - it was coercive control and it didn't appear on my TV screens".
But, a decade on, "we're not tackling it enough", he added.
"I continue to speak out because I don't want these events to happen again."
Wife's murder conviction quashed
'My mum killed my dad but I want her freed'
HM Courts & Tribunals Service
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New York Post
5 days ago
- New York Post
Former NY gov David Paterson sues brother for stealing $7 m
Cain and Abel, meet David and Daniel. Ex-New York Gov. David Paterson is accusing his brother of cheating him out of his inheritance — by allegedly tricking their elderly mother into giving him over $7 million before her death. A bombshell lawsuit filed by the former governor claims his younger brother Daniel Paterson, 67, duped mom Portia into transferring the massive sum from her estate to his account through 'undue influence, coercion and excessive persuasion.' The sneaky move allowed Daniel and his attorney wife Eloise to bypass a long-standing will ordering the brothers to split their mom's estate 50-50 — cheating David, 71, out of some $3.5 million, the Manhattan Supreme Court suit alleges. 'She divested herself of assets in excess of $7 million by transferring [the] same to defendants prior to her death in contradiction and contravention of her long-standing last will and testament,' the court documents, filed Monday, state. 4 Former New York Gov David Paterson (left) says his brother Daniel (right) tricked their 94-year-old mother into transferring over $7 million from her estate to him, according to a new lawsuit. Robert Miller Then, after 94-year-old Portia Paterson's death in July, Daniel allegedly tried to claim that their mom died with less than $30,000 to her name in a checking account and an 'inoperable' BMW, the suit alleges. The 55th Governor — a Democrat who was in office between 2008-2010 — is suing his brother, sister-in-law and two nephews for his alleged at least $3.5 million share of Portia's estate. 'There was a conspiracy to conceal that Portia's assets were transferred before her death,' said the former gov's attorney, Paul W. Siegert. 'She had a huge estate. 4 Lt Gov Basil Paterson and wife Portia at fund raising party for peace candidates, at 'Pembles' in 1970. She passed away last July at 94. Jerry Engel/NY Post 'Everybody kept it a secret,' Siegert said, 'then we found out about it.' Daniel, who has worked for the state court system's office of diversity and inclusion, told a reporter that 'this must be a scam call' when reached by phone Tuesday, and quickly hung up. He did not return repeated messages asking for comment. Portia Paterson was married for 61 years to Basil Paterson, who was the first black vice chair of the National Democratic Party, and the first black secretary of state of New York. 4 The former governor's lawsuit alleges that leading up to her death, Daniel and his attorney wife Eloise (center) tricked the 94-year-old to transfer millions through 'undue influence, coercion and excessive persuasion.' AP She was a longtime school teacher at P.S. 116 in Jamaica, a guidance counselor at Queens College, and was a known advocate for disabled students like her son David, who is legally blind. The ex-gov claims he only learned about the alleged 'unjust enrichment' last month after Daniel filed an affidavit to settle his mother's estate in surrogate's court. David's attorney then said he got a notice from the court, leading to the shocking discovery that his brother was claiming their late mother only had a $27,000 bank account and an 'inoperable' 2011 BMW 5-series valued at $2,000. On top of that, the affidavit claimed $8,500 in funeral expenses to be subtracted from the estate. That means the former governor's share of what was once his mother's sizable estate would be a mere $10,250. 4 Basil Paterson, his wife Portia, and their sons Daniel and David at JFK airport in 1970. Vic DeLucia/NY Post 'Even Portia's lawyer of 30 years – who wrote her will – did not know that Portia had transferred $7,000,000 in assets,' Siegert said. Daniel, the executor of Portia's estate, allegedly never even notified her estate lawyers of her death, Siegert claimed. 'How could she die in July of 2024, and we only find out almost a year later that her will was not being probated and then out of the blue, we get a notice from the surrogate's court that her net estate is $21,500,' the attorney said. 'Draw your own conclusions.'
Yahoo
5 days ago
- Yahoo
UnitedHealth Group Incorporated (UNH) CEO Is In A 'Bunker,' Laments Jim Cramer
UnitedHealth Group Incorporated (NYSE:UNH) is one of the . UnitedHealth Group Incorporated (NYSE:UNH) is one of the biggest healthcare benefits managers in America. It is also one of the most troubled stocks in its sector. UnitedHealth Group Incorporated (NYSE:UNH)'s shares have lost 37.9% year-to-date on the back of a massive 27% drop in April. The shares sank after a disastrous earnings report for the first quarter saw it miss analyst estimates and lower full-year outlook. Cramer has discussed UnitedHealth Group Incorporated (NYSE:UNH) several times in his show. He believes that recent reports of the firm being investigated might be untrue since its management has continued to buy shares. Here are his latest thoughts about UnitedHealth Group Incorporated (NYSE:UNH): 'Hey by the way, there was a downgrade of UNH, UnitedHealth. It's time for that CEO to start appearing somewhere. He's in a bunker right now. The bunker's a bad place.' Cramer has discussed UnitedHealth Group Incorporated (NYSE:UNH)'s insider buying in quite a bit of detail. Here are his recent remarks: 'People sell things for many reasons, right. They get divorced, I don't know about that. They get maybe something happens in their family, they need money. But David, why do they buy? Sometimes they buy because there's a bargain. Now typically these insiders, maybe they buy like 1500 shares. Well how about if you bought, you're Stephen Hemsley, returning CEO, who acquired 86,000 shares at 288. That's pretty, you know 25 mil. A senior healthcare professional giving advice to a patient in a clinic. 'And then, Kristen Gil, director, what, 3700 shares. Timothy Patrick, director, 1553. The CFO, come right in, the CFO's in there buying the heck out of it too. 5 million. So I just say to myself, if they really knew, like the Journal says that they're being investigated criminally, that's a very big buy that would obviously go away. While we acknowledge the potential of UNH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
6 days ago
- Yahoo
Medtech earnings estimates may see 'significant' upward revisions
Tariffs have been weighing on medical device makers' earnings outlook all year. David Roman, Goldman Sachs head of US medtech and healthcare IT research, joins Market Domination to explain why many in the medtech industry are now set up for upward revisions of earnings estimates. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. as you had the chance to talk to folks in the MedTech industry here, it seems like one of the biggest headwinds this year has been concerned over tariffs, right? And the fact that at least some of this stuff gets made in China and other areas abroad and imported here to the US. So I'd love to start there and get your take on what you're hearing from these companies. Excellent. Uh, thank you for having me today. Uh, so you're right. Tariffs has been a major concern for investors. That did drive companies to lower their outlooks for 2025 on most recent earnings calls. If you listen to the first quarter earnings calls, most companies did take take reductions reflecting the then in place tariffs. If you look at MedTech though in context, about 70% of medical devices sold in the US are actually made in the US. This is a significant amount of onshore manufacturing. And unlike some other parts of healthcare where you do see the move of IP around the world for for to to manage effective tax rates, MedTech R&D is very heavily domiciled in the US. So as we as we reflect on kind of where tariff policy sits today, we actually expect fairly significant upward revisions and earnings estimates as we go through second quarter earnings, uh, to take into account what are obviously tariff rates that are moderated, especially on China from what we saw during the April, uh, April earnings season. That's those supply chain stats are interesting, David. How has it always been like that or has there been a shift in the last 5 or 10 years in that industry? So it's actually been a pretty long-standing strategy for MedTech companies to manufacture where they sell. And and and I think it's it's a good point because that trend did accelerate during, uh, the first round, the first Trump administration when tariffs went into place. But remember, the medical device industry is very much a manufacturing industry. So things like freight and logistics costs do go into the calculation when companies think about where to put manufacturing. It also allows them to compete locally. So for example, most take GE Healthcare, who has about 12% of their revenue in China, something like 70 to 80% of what they manu of what they sell in China is manufactured, uh, and sourced locally. And that puts them in a position to be able to compete effectively with companies who are domestically headquartered there. The same is true in the US. Uh, companies try to put manufacturing very close to where they do R&D, and the reason for that is rapid prototyping and, um, trying to accelerate the development of products because this is very much a iterative industry. Putting product development and manufacturing closely aligned to one another has actually been a competitive advantage for several companies.